Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2008
12/04/2008US20080300277 Process to improve stability of a pharmaceutical composition
12/04/2008US20080300219 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
12/04/2008US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands
12/04/2008US20080299220 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/04/2008US20080299211 Fexofenadine suspension formulation
12/04/2008US20080299210 Stable nanosized amorphous drug
12/04/2008US20080299209 Novel Formulations of Fat-Soluble Active Ingredients with High Biovailability
12/04/2008US20080299208 Anisometric Particles In The Form Of Nanofibers/Mesofibers,Nanopipes, Nanocables/Mesocables, Nanobands/Mesobands, And The Curved Or Branched Variations Thereof
12/04/2008US20080299207 Methods and compositions for administration of oxybutynin
12/04/2008US20080299206 Ophthalmic preparations
12/04/2008US20080299205 Particulate Constructs For Release of Active Agents
12/04/2008US20080299204 Dosage forms for movement disorder treatment
12/04/2008US20080299203 Solid Pharmaceutical Dosage Formulation
12/04/2008US20080299202 Controlled-Delivery System of Pharmacologically Active Substances, Preparation Process and Medical Use Thereof
12/04/2008US20080299201 Devices, methods, and systems for accessing native neurons through artificial neural mediators (anms)
12/04/2008US20080299200 Oil-in-Water Emulsion for Creating New Product Consistencies
12/04/2008US20080299199 Swellable Dosage Form Comprising Gellan Gum
12/04/2008US20080299198 Polystyrene sulfonate polymer tablets, their preparation and use
12/04/2008US20080299197 Triple Combination Release Multi-Layered Tablet
12/04/2008US20080299196 Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
12/04/2008US20080299195 Use of ranolazine for elevated brain-type natriuretic peptide
12/04/2008US20080299194 Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets
12/04/2008US20080299193 Pharmaceutical composition comprising eszoplicone
12/04/2008US20080299192 Intraorally Rapidly Disintergrating Tablets and Their Production
12/04/2008US20080299191 Fine-Particle Crosslinked Polyvinylpyrrolidone as Tablet Disintegrant
12/04/2008US20080299190 Direct Compression Formulation and Process
12/04/2008US20080299189 Controlled release dopamine agonist compositions
12/04/2008US20080299188 Controlled release dosage forms combining immediate release and sustainted release of low-solubility drug
12/04/2008US20080299187 Substances for Reducing Occurence of Major Cardiac Events in Humans
12/04/2008US20080299186 Coatings for applying substances onto substrate carrier
12/04/2008US20080299185 Comprising at least one digestive enzyme (e.g., pancrelipase); useful for treating or preventing disorders associated with digestive enzyme deficiencies; enteric coated enzyme compositions and dosage forms that exhibit minimal loss of activity under typical storage conditions
12/04/2008US20080299184 diagnosing nonsmall cell lung cancer by analyzing PCDH20 gene in a lung sample; measurement of the expression level of the cancer-suppressing gene and methylation of genomic DNA
12/04/2008US20080299182 Methods and formulations for topical gene therapy
12/04/2008US20080299181 Odourless garlic supplement comprising an enteric coating and a deodorising layer
12/04/2008US20080299180 Peptides based on the sequence of human lactoferrin and their use
12/04/2008US20080299178 Sustained release intraocular implants and methods for preventing retinal dysfunction
12/04/2008US20080299177 Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
12/04/2008US20080299172 Tissue repair implant
12/04/2008US20080299168 Stabilized Polymeric Delivery System
12/04/2008US20080299166 Novel biomaterials, their preparation and use
12/04/2008US20080299165 Compositions for Treatment of Diseases of the Nail Unit
12/04/2008US20080299164 Substituted polycaprolactone for coating
12/04/2008US20080299160 Method of Manufacture of Polymer Composites
12/04/2008US20080299157 Skin care compositions having unique texture properties
12/04/2008US20080299156 Skin care compositions containing a high internal phase emulsion
12/04/2008US20080299092 Cosmetic preparation and method for preparing the same
12/04/2008US20080299089 Endogeneous repair factor production promoters
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299049 Inhalation nebulizer
12/04/2008US20080299048 Mixed drug aerosol compositions
12/04/2008US20080299046 Methods for controlling surface functionality of metal oxide nanoparticles, metal oxide nanoparticles having controlled functionality, and uses thereof
12/04/2008US20080299043 having superior solubility anf miscibility with membrane components of liposomes; suitable for a liposome contrast medium selective for a lesion such as vascular diseases; chelate compound
12/04/2008US20080299005 film made of water soluble polymer such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose, a reagent such as protein, hormone, antibody and an enzyme; film disintegrates upon contact with an aqueous fluid to release the reagent which reacts human chorionic gonadotrophin in saliva, urine, blood
12/04/2008US20080296196 Injection Molded Water-Soluble Container
12/04/2008US20080295960 Silicone Adhesive For Adhesion To Wet Surfaces
12/04/2008DE102007034676A1 Kommunikationsmodul mit einem Biomodulator Communication module with a biomodulator
12/04/2008DE102007025858A1 Verfahren zur Herstellung einer Arzneimitteldarreichungsform A process for preparing a Arzneimitteldarreichungsform
12/04/2008CA2716159A1 Stable non-aqueous pharmaceutical compositions
12/04/2008CA2689066A1 Reconstituted surfactants having improved properties
12/04/2008CA2688570A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
12/04/2008CA2688486A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008CA2688381A1 Once daily oral dosage form comprising tacrolimus
12/04/2008CA2688318A1 Whitening agent
12/04/2008CA2688164A1 Methods of making and using nano scale particles
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008CA2687983A1 Coated hyaluronic acid particles
12/04/2008CA2687794A1 Spherical particle of crystalline mannitol
12/04/2008CA2687381A1 Method of treating diabetes
12/04/2008CA2687367A1 Oil-in-water emulsion and its use for the delayed release of active elements
12/04/2008CA2687310A1 Rapidly dispersible vaginal tablet that provides a bioadhesive gel
12/04/2008CA2686566A1 Multi-dose concentrate esmolol with benzyl alcohol
12/04/2008CA2686560A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/04/2008CA2667473A1 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
12/03/2008EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2008EP1997952A2 Method for producing an electrically conductive thread, textile structure for a transdermal active ingredient reservoir and method for storing active ingredient
12/03/2008EP1997887A1 Multimer of extracellular domain of cell surface functional molecule
12/03/2008EP1997520A2 Patch and patch preparation
12/03/2008EP1997505A1 Erythropoietin solution preparation
12/03/2008EP1997502A1 Reconstituted surfactants having improved properties
12/03/2008EP1997497A2 Compositions and methods for treating a posterior segment of an eye
12/03/2008EP1997483A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system
12/03/2008EP1997482A1 A pharmaceutical composition comprising eszopiclone
12/03/2008EP1997481A1 Solid oral form of a medicinal preparation and a method for the production thereof
12/03/2008EP1997480A1 Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid
12/03/2008EP1997479A1 Stabilized amorphous candesartan cilexetil compositions for oral administration
12/03/2008EP1997478A2 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
12/03/2008EP1997477A1 Anti-acne skin agent for external use
12/03/2008EP1997456A1 Drug coating device and method for wire filaments
12/03/2008EP1996640A1 Microparticles comprising a crosslinked polymer
12/03/2008EP1996612A1 Compositions for treatment of cancer
12/03/2008EP1996292A1 Use of peptides for the control of radiation injury
12/03/2008EP1996239A2 Compositions for visualization of vitreous body and methods of using same
12/03/2008EP1996224A1 Mixtures of amylin and insulin
12/03/2008EP1996211A1 Gallium compositions for the treatment of liver cancer and methods of use
12/03/2008EP1996208A2 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
12/03/2008EP1996204A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug
12/03/2008EP1996203A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug
12/03/2008EP1996199A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity
12/03/2008EP1996173A2 Powder filling processes
12/03/2008EP1996172A1 Plaster packaging
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 2991